The Registry of Toxic Effects of Chemical Substances
Acrylonitrile |
UPDATE: May 2005 | MW: 53.07 | MF: C3H3N |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
eye | rabbit
100 mg
|
moderate
|
ATDAEI 1,114,1990
|
skin | human
500 mg rinse
|
moderate
|
INMEAF 17,199,1948
|
skin | rabbit
500 mg
|
severe
|
ATDAEI 1,114,1990
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
body fluid assay
|
mouse
| Salmonella typhimurium
30 mg/kg
|
TXCYAC 16,67,1980
|
body fluid assay
|
rat
| Salmonella typhimurium
30 mg/kg
|
TXCYAC 16,67,1980
|
cytogenetic analysis
|
hamster
ovary
|
4 mmol/L
|
PMRSDJ 5,433,1985
|
cytogenetic analysis
|
hamster
lung
|
6,250 µg/L
|
PMRSDJ 5,427,1985
|
cytogenetic analysis
|
hamster
liver
|
2,500 µg/L
|
PMRSDJ 5,397,1985
|
cytogenetic analysis
|
inhalation | human
0.8 mg/m3/146 week
|
MUREAV 537,93,2003
|
DNA adduct
|
mammal (species unspecified)
lymphocyte
|
68 mmol/L
|
CBINA8 51,167,1984
|
DNA adduct
|
oral | rat
46,500 µg/kg
|
CBINA8 47,363,1983
|
DNA adduct
|
rat
liver
|
16,500 µmol/L
|
XENOBH 13,19,1983
|
DNA damage
|
hamster
ovary
|
3,710 mg/L
|
PMRSDJ 5,359,1985
|
DNA damage
|
hamster
embryo
|
200 mg/L
|
JJIND8 62,1025,1979
|
DNA damage
|
human
other cell types
|
200 mg/L
|
MUREAV 241,355,1990
|
DNA damage
|
inhalation | human
0.8 mg/m3/146 week
|
MUREAV 537,93,2003
|
unscheduled DNA synthesis
|
rat
liver
|
1 mmol/L
|
PMRSDJ 5,371,1985
|
unscheduled DNA synthesis
|
oral | rat
50 mg/kg
|
CNREA8 46,3932,1986
|
mutation in microorganisms
|
Escherichia coli
|
300 µmol/L (-enzymatic activation step)
|
MUREAV 45,283,1977
|
mutation in microorganisms
|
human
lymphocyte
|
40 mg/L (+enzymatic activation step)
|
PMRSDJ 5,497,1985
|
mutation in microorganisms
|
mouse
lymphocyte
|
161 mg/L (+enzymatic activation step)
|
FCTOD7 23,115,1985
|
mutation in microorganisms
|
mouse
embryo
|
50 mg/L (+enzymatic activation step)
|
PMRSDJ 5,639,1985
|
mutation in microorganisms
|
Salmonella typhimurium
|
25 µL/plate (+enzymatic activation step)
|
NIOSH* 5AUG1977
|
mutation in microorganisms
|
Salmonella typhimurium
|
57 ppm (-enzymatic activation step)
|
MUREAV 48,271,1977
|
mutation in microorganisms
|
Saccharomyes cerevisiae
|
800 µg/L (+/-enzymatic activation step)
|
PMRSDJ 5,271,1985
|
micronucleus test
|
hamster
ovary
|
100 mmol/L
|
PMRSDJ 5,359,1985
|
gene conversion and mitotic recombination
|
Aspergillus nidulans
|
806 mg/L
|
PMRSDJ 5,307,1985
|
gene conversion and mitotic recombination
|
Saccharomyes cerevisiae
|
14 mg/L
|
PMRSDJ 5,225,1985
|
mutation in mammalian somatic cells
|
human
lymphocyte
|
25 mg/L
|
PMRSDJ 5,497,1985
|
mutation in mammalian somatic cells
|
mouse
lymphocyte
|
12,500 nL/L
|
PMRSDJ 5,555,1985
|
morphological transform
|
hamster
embryo
|
2 mg/L
|
PMRSDJ 5,665,1985
|
morphological transform
|
hamster
embryo
|
50 mg/L/7 day
|
CRNGDP 21,727,2000
|
morphological transform
|
mouse
embryo
|
8,800 µg/L
|
PMRSDJ 5,639,1985
|
morphological transform
|
mouse
fibroblast
|
6,300 µg/L
|
CALEDQ 32,293,1986
|
other mutation test systems
|
oral | rat
46,500 µg/kg
|
CBINA8 47,363,1983
|
other mutation test systems
|
rat
liver
|
16,500 µmol/L
|
XENOBH 13,19,1983
|
other mutation test systems
|
Saccharomyes cerevisiae
|
500 ppm
|
EESADV 8,162,1984
|
sister chromatid exchange
|
hamster
ovary
|
2 mmol/L
|
PMRSDJ 5,433,1985
|
sister chromatid exchange
|
human
other cell types
|
150 mg/L
|
MUREAV 241,355,1990
|
sex chromosome loss and nondisjunction
|
Aspergillus nidulans
|
4,800 mg/L
|
MUREAV 147,288,1985
|
sex chromosome loss and nondisjunction
|
inhalation | Drosophila melanogaster
3 ppm
|
MUREAV 259,165,1991
|
specific locus test
|
oral | Drosophila melanogaster
1,520 µmol/L
|
PMRSDJ 5,325,1985
|
specific locus test
|
oral | mouse
600 mg/kg/6 week- intermittent
|
TOXID9 72(Supp 1),228,2003
|
sperm morphology
|
inhalation | human
0.8 mg/m3/146 week
|
MUREAV 537,93,2003
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | rat
lowest published toxic concentration: 40 ppm/6 hour (6-15 day pregnant)
|
Reproductive: Other effects on female | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
FCTXAV 16,547,1978
|
inhalation | rat
lowest published toxic concentration: 80 ppm/6 hour (6-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system
|
FCTXAV 16,547,1978
|
inhalation | rat
lowest published toxic concentration: 25 ppm/6 hour (6-20 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
FAATDF 20,365,1993
|
intraperitoneal | hamster
lowest published toxic dose: 641 mg/kg (8 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Specific developmental abnormalities: Central nervous system
TJADAB 23,317,1981
|
intraperitoneal | hamster
lowest published toxic dose: 641 mg/kg (8 day pregnant)
|
Reproductive: Effects on embryo or fetus: Extra embryonic structures (e.g., placenta, umbilical cord) | Reproductive: Effects on embryo or fetus: Cytological changes (including somatic cell genetic material) Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
TJADAB 23,325,1981
|
intraperitoneal | hamster
lowest published toxic dose: 641 mg/kg (8 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Specific developmental abnormalities: Musculoskeletal system
TJADAB 23,325,1981
|
intraperitoneal | mouse
lowest published toxic dose: 32 mg/kg (5 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
ZHYGAM 26,564,1980
|
oral | mouse
lowest published toxic dose: 600 mg/kg (60 day male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Paternal effects: Testes, epididymis, sperm duct Reproductive: Other effects on male
TOLED5 42,55,1988
|
oral | rat
lowest published toxic dose: 650 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on fertility: Female fertility index (e.g., # females pregnant per # sperm positive females; # females pregnant per # females mated) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Specific developmental abnormalities: Musculoskeletal system
DOWCC* 03NOV1976
|
oral | rat
lowest published toxic dose: 650 mg/kg (6-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system | Reproductive: Specific developmental abnormalities: Cardiovascular (circulatory) system
TJADAB 17,50A,1978
|
oral | rat
lowest published toxic dose: 644 mg/kg (2 week male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Paternal effects: Testes, epididymis, sperm duct
TOXID9 14,87,1994
|
oral | rat
lowest published toxic dose: 650 mg/kg (6-15 day pregnant)
|
Reproductive: Other effects on female | Reproductive: Specific developmental abnormalities: Musculoskeletal system Reproductive: Specific developmental abnormalities: Cardiovascular (circulatory) system
NTIS** OTS0555785
|
oral | rat
lowest published toxic dose: 100 mg/kg (10 day pregnant)
|
Reproductive: Other effects to embryo or fetus
|
TXAPA9 163,149,2000
|
oral | rat
lowest published toxic dose: 9.5 gm/kg (14 week male/14 week prior to copulation-3 week after birth)
|
Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive) | Reproductive: Effects on newborn: Weaning or lactation index (e.g., # alive at weaning per # alive at day 4) Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
TOLED5 132,249,2002
|
oral | rat
lowest published toxic dose: 5.7 gm/kg (22 week male/22 week prior to copulation-3 week after birth)
|
Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive)
|
TOLED5 132,249,2002
|
oral | rat
lowest published toxic dose: 5,727 mg/kg (multigeneration)
|
Reproductive: Effects on fertility: Mating performance (e.g., # sperm positive females per # females mated; # copulations per # estrus cycles) | Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
TOLED5 132,249,2002
|
oral | rat
lowest published toxic dose: 13.8 mg/kg (multigeneration)
|
Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive) | Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
TOLED5 132,249,2002
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | rat
lowest published toxic concentration: 5 ppm/52 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Skin and Appendages: Tumors
MELAAD 68,401,1977
|
inhalation | rat
toxic concentration (other than lowest) : 20 ppm/4 hour/52 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Brain and Coverings: Tumors
ANYAA9 381,216,1982
|
inhalation | rat
toxic concentration (other than lowest) : 40 ppm/4 hour/52 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Brain and Coverings: Tumors
ANYAA9 381,216,1982
|
oral | mouse
lowest published toxic dose: 10,400 mg/kg/104 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Gastrointestinal: Tumors
NTIS** PB2002-102198
|
oral | rat
lowest published toxic dose: 18,200 mg/kg/52 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Brain and Coverings: Tumors
FCTOD7 24,129,1986
|
oral | rat
toxic dose : 3,640 mg/kg/52 week- continuous
|
Tumorigenic: Neoplastic by RTECS criteria | Ear: Tumors Gastrointestinal: Tumors
DOWCC* MAR1977
|
oral | rat
lowest published toxic dose: 2,490 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Brain and Coverings: Other degenerative changes Gastrointestinal: Tumors
NTIS** OTS0540235
|
oral | rat
lowest published toxic dose: 960 mg/kg/48 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Reproductive: Other reproductive system tumors
TOLED5 132,249,2002
|
oral | rat
lowest published toxic dose: 6,000 mg/kg/600 day- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Brain and Coverings: Tumors
TOLED5 132,197,2002
|
oral | rat
lowest published toxic dose: 6,420 mg/kg/600 day- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Ear: Tumors
TOLED5 132,197,2002
|
oral | rat
lowest published toxic dose: 4,800 mg/kg/600 day- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Ear: Tumors
TOLED5 132,197,2002
|
oral | rat
lowest published toxic dose: 2,693.6 mg/kg/2 year- continuous
|
Tumorigenic: Neoplastic by RTECS criteria | Brain and Coverings: Tumors
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 1,820 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Brain and Coverings: Tumors
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 6,115.2 mg/kg/2 year- continuous
|
Tumorigenic: Neoplastic by RTECS criteria | Spinal Cord: Tumors
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 946.4 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Ear: Tumors
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 218.4 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Gastrointestinal: Tumors Skin and Appendages: Tumors
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 72.8 mg/kg/2 year- continuous
|
Tumorigenic: Neoplastic by RTECS criteria | Endocrine: Tumors
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 7,280 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria
|
TOLED5 132,153,2002
|
oral | rat
lowest published toxic dose: 21.84 gm/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Brain and Coverings: Tumors
TOLED5 132,153,2002
|
oral | rat
lowest published toxic dose: 7,280 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Gastrointestinal: Tumors Gastrointestinal: Colon tumors
TOLED5 132,153,2002
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | cat
lowest published lethal concentration: 600 ppm/4 hour
|
Behavioral: Convulsions or effect on seizure threshold | Lung, Thorax, or Respiration: Dyspnea Gastrointestinal: Nausea or vomiting
JIHTAB 24,27,1942
|
inhalation | dog
lowest published lethal concentration: 110 ppm/4 hour
|
Peripheral Nerve and Sensation: Flaccid paralysis without anesthesia (usually neuromuscular blockage) | Behavioral: Convulsions or effect on seizure threshold Behavioral: Coma
JIHTAB 24,27,1942
|
inhalation | guinea pig
lowest published lethal concentration: 575 ppm/4 hour
|
Eye: Lacrimation | Lung, Thorax, or Respiration: Acute pulmonary edema Lung, Thorax, or Respiration: Cough
JIHTAB 24,27,1942
|
inhalation | human
lowest published toxic concentration: 16 ppm/20 minute
|
Olfaction: Other olfaction effects | Eye: Conjunctiva irritation Lung, Thorax, or Respiration: Other changes
INMEAF 17,199,1948
|
inhalation | man
lowest published lethal concentration: 1 gm/m3/1 hour
|
Behavioral: Somnolence (general depressed activity) | Gastrointestinal: Hypermotility, diarrhea Gastrointestinal: Nausea or vomiting
ZAARAM 16,1,1966
|
inhalation | monkey
lethal concentration : >90 ppm/4 hour
|
N/R
|
NTIS** PB280-478
|
inhalation | rat
lethal concentration (50 percent kill): 333 ppm/4 hour
|
Eye: Lacrimation | Behavioral: Tremor Lung, Thorax, or Respiration: Dyspnea
NTIS** OTS0571605
|
inhalation | rat
lowest published toxic concentration: 350 mg/m3/6 hour
|
Liver: Other changes | Endocrine: Hyperglycemia Biochemical: Metabolism (intermediary): Other
TXCYAC 65,209,1990
|
inhalation | rabbit
lowest published lethal concentration: 260 ppm/4 hour
|
Behavioral: Convulsions or effect on seizure threshold | Behavioral: Coma Lung, Thorax, or Respiration: Dyspnea
JIHTAB 24,27,1942
|
intraperitoneal | mouse
lethal dose (50 percent kill): 46 mg/kg
|
Eye: Corneal damage | Behavioral: Ataxia Lung, Thorax, or Respiration: Dyspnea
TXAPA9 59,589,1981
|
intraperitoneal | rat
lethal dose (50 percent kill): 65 mg/kg
|
N/R
|
AMPMAR 36,58,1975
|
intravenous | dog
lowest published lethal dose: 200 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Gastrointestinal: Nausea or vomiting Lung, Thorax, or Respiration: Respiratory depression
TXAPA9 7,367,1965
|
intravenous | rabbit
lethal dose (50 percent kill): 69 mg/kg
|
Peripheral Nerve and Sensation: Flaccid paralysis with appropriate anesthesia | Behavioral: Tremor Behavioral: Convulsions or effect on seizure threshold
NTIS** PB280-478
|
oral | guinea pig
lethal dose (50 percent kill): 50 mg/kg
|
N/R
|
ZHYGAM 16,316,1970
|
oral | mouse
lethal dose (50 percent kill): 27 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Lung, Thorax, or Respiration: Dyspnea Gastrointestinal: Changes in structure or function of salivary glands
JHEMA2 3,106,1959
|
oral | mouse
lowest published toxic dose: 2.5 mg/kg
|
Blood: Other changes
|
TOXID9 72,319,2003
|
oral | rat
lethal dose (50 percent kill): 78 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Lung, Thorax, or Respiration: Dyspnea Gastrointestinal: Changes in structure or function of salivary glands
JHEMA2 3,106,1959
|
subcutaneous | guinea pig
lethal dose (50 percent kill): 130 mg/kg
|
Peripheral Nerve and Sensation: Flaccid paralysis with appropriate anesthesia | Behavioral: Tremor Behavioral: Convulsions or effect on seizure threshold
NTIS** PB280-478
|
subcutaneous | mouse
lethal dose (50 percent kill): 25 mg/kg
|
Eye: Other eye effects | Behavioral: Change in motor activity (specific assay) Gastrointestinal: Hypermotility, diarrhea
TXAPA9 7,367,1965
|
subcutaneous | mouse
lethal dose (50 percent kill): 36 mg/kg
|
N/R
|
EKFAE9 61,56,1998
|
subcutaneous | mouse
lowest published toxic dose: 18 mg/kg
|
Immunological Including Allergic: Decreased immune response
|
EKFAE9 61,56,1998
|
subcutaneous | rat
lethal dose (50 percent kill): 75 mg/kg
|
Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change | Behavioral: Convulsions or effect on seizure threshold Lung, Thorax, or Respiration: Cyanosis
TXAPA9 102,142,1990
|
subcutaneous | rat
lethal dose (50 percent kill): 75 mg/kg
|
N/R
|
EKFAE9 61,56,1998
|
subcutaneous | rat
lowest published toxic dose: 37.5 mg/kg
|
Immunological Including Allergic: Decrease in cellular immune response | Immunological Including Allergic: Decrease in humoral immune response
EKFAE9 61,56,1998
|
skin | child
lowest published lethal dose: 2,015 mg/kg
|
Behavioral: General anesthetic | Lung, Thorax, or Respiration: Cyanosis Gastrointestinal: Nausea or vomiting
DMWOAX 75,1087,1950
|
skin | guinea pig
lethal dose (50 percent kill): 202 mg/kg
|
N/R
|
JIHTAB 30,63,1948
|
skin | rat
lethal dose (50 percent kill): 148 mg/kg
|
N/R
|
GISAAA 41(10),103,1976
|
skin | rabbit
lethal dose (50 percent kill): 63 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Skin: After systemic exposure: Dermatitis, other
NTIS** OTS0534646
|
unreported route | rat
lowest published lethal dose: 200 mg/kg
|
Endocrine: Other changes
|
TXAPA9 37,133,1976
|
unreported route | rat
lethal dose : 115 mg/kg
|
Liver: Other changes | Biochemical: Metabolism (intermediary): Other proteins
TOXID9 72,95,2003
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | cat
lowest published toxic concentration: 330 mg/m3/4 hour/8 week- intermittent
|
Olfaction: Other olfaction effects | Eye: Conjunctiva irritation Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
JIHTAB 24,255,1942
|
inhalation | guinea pig
lowest published toxic concentration: 330 mg/m3/4 hour/8 week- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
JIHTAB 24,255,1942
|
inhalation | guinea pig
lowest published toxic concentration: 4 gm/kg/325 day- intermittent
|
Lung, Thorax, or Respiration: Fibrosis, focal (pneumoconiosis) | Lung, Thorax, or Respiration: Other changes
CRTXB2 31,697,2001
|
inhalation | monkey
lowest published toxic concentration: 330 mg/kg/4 hour/8 week- intermittent
|
Behavioral: Muscle weakness | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
JIHTAB 24,255,1942
|
inhalation | mouse
lowest published toxic concentration: 60 mg/m3/4 hour/21 day- intermittent
|
Endocrine: Changes in spleen weight | Endocrine: Changes in thymus weight Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases
WDZAEK 4,245,1990
|
inhalation | rat
lowest published toxic concentration: 1,500 µg/m3/5 hour/26 week- intermittent
|
Liver: Other changes | Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases
GTPZAB 27(4),50,1983
|
inhalation | rat
lowest published toxic concentration: 330 mg/kg/4 hour/8 week- intermittent
|
Olfaction: Other olfaction effects | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
JIHTAB 24,255,1942
|
inhalation | rabbit
lowest published toxic concentration: 330 mg/m3/4 hour/8 week- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
JIHTAB 24,255,1942
|
intraperitoneal | rat
lowest published toxic dose: 99 mg/kg/3 day- intermittent
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Nutritional and Gross Metabolic: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
TOLED5 6,399,1980
|
oral | dog
lowest published toxic dose: 900 mg/kg/26 week- intermittent
|
Behavioral: Somnolence (general depressed activity) | Lung, Thorax, or Respiration: Other changes Musculoskeletal: Other changes
NTIS** OTS0555089
|
oral | rat
lowest published toxic dose: 1,440 mg/kg/12 week- intermittent
|
Behavioral: Excitement | Liver: Other changes Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
WDZAEK 5,24,1991
|
oral | rat
lowest published toxic dose: 10,920 mg/kg/1 year- continuous
|
Behavioral: Food intake (animal) | Kidney, Ureter, and Bladder: Other changes in urine composition Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
DOWCC* MAR1977
|
oral | rat
lowest published toxic dose: 2,100 mg/kg/21 day- continuous
|
Endocrine: Other changes | Nutritional and Gross Metabolic: Changes in: Na
TXAPA9 37,133,1976
|
oral | rat
lowest published toxic dose: 120 mg/kg/60 day- intermittent
|
Endocrine: Adrenal cortex hyperplasia | Endocrine: Changes in adrenal weight Blood: Other changes
JJATDK 4,131,1984
|
oral | rat
lowest published toxic dose: 945 mg/kg/90 day- continuous
|
Liver: Changes in liver weight | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NTIS** OTS0555089
|
oral | rat
lowest published toxic dose: 750 mg/kg/12 week- intermittent
|
Peripheral Nerve and Sensation: Recording from peripheral motor nerve | Behavioral: Excitement Gastrointestinal: Changes in structure or function of salivary glands
JJATDK 18,25,1998
|
oral | rat
lowest published toxic dose: 6,000 mg/kg/600 day- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
TOLED5 132,197,2002
|
oral | rat
lowest published toxic dose: 4,200 mg/kg/420 day- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
TOLED5 132,197,2002
|
oral | rat
lowest published toxic dose: 2,400 mg/kg/300 day- continuous
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
TOLED5 132,197,2002
|
oral | rat
lowest published toxic dose: 3,640 mg/kg/364 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
TOLED5 132,197,2002
|
oral | rat
lowest published toxic dose: 2,912 mg/kg/364 day- continuous
|
Endocrine: Changes in pituitary weight | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TOLED5 132,197,2002
|
oral | rat
lowest published toxic dose: 6,600 mg/kg/660 day- intermittent
|
Blood: Normocytic anemia | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)
TOLED5 132,197,2002
|
oral | rat
lowest published toxic dose: 1,440 mg/kg/180 day- continuous
|
Blood: Normocytic anemia
|
TOLED5 132,197,2002
|
oral | rat
lowest published toxic dose: 5,280 mg/kg/660 day- continuous
|
Blood: Changes in leukocyte (WBC) count
|
TOLED5 132,197,2002
|
oral | rat
lowest published toxic dose: 54.6 mg/kg/546 day- intermittent
|
Liver: Changes in liver weight
|
TOLED5 132,197,2002
|
oral | rat
lowest published toxic dose: 6,000 mg/kg/600 day- intermittent
|
Endocrine: Changes in adrenal weight
|
TOLED5 132,197,2002
|
oral | rat
lowest published toxic dose: 5,460 mg/kg/546 day- intermittent
|
Kidney, Ureter, and Bladder: Changes in kidney weight
|
TOLED5 132,197,2002
|
oral | rat
lowest published toxic dose: 6,420 mg/kg/600 day- continuous
|
Endocrine: Changes in pituitary weight
|
TOLED5 132,197,2002
|
oral | rat
lowest published toxic dose: 59.4 mg/kg/660 day- continuous
|
Gastrointestinal: Other changes
|
TOLED5 132,197,2002
|
oral | rat
lowest published toxic dose: 3,528 mg/kg/420 day- continuous
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 140 mg/kg/56 day- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 991.9 mg/kg/13 week- continuous
|
Behavioral: Food intake (animal)
|
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 3,924 mg/kg/360 day- continuous
|
Blood: Normocytic anemia
|
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 5,886 mg/kg/540 day- continuous
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 72.8 mg/kg/2 year- continuous
|
Liver: Changes in liver weight | Kidney, Ureter, and Bladder: Changes in kidney weight Endocrine: Changes in adrenal weight
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 2,693.6 mg/kg/2 year- continuous
|
Cardiac: Changes in heart weight | Liver: Changes in liver weight
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 946.4 mg/kg/2 year- continuous
|
Eye: Retinal changes pigmentary deposition, retinitis, other) | Vascular: Thromobosis distant from injection site Reproductive: Maternal effects: Ovaries, fallopian tubes
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 291.2 mg/kg/2 year- continuous
|
Gastrointestinal: Other changes | Blood: Changes in spleen
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 72.8 mg/kg/2 year- continuous
|
Liver: Other changes | Reproductive: Maternal effects: Uterus, cervix, vagina Reproductive: Maternal effects: Breasts, lactation (prior to or during pregnancy)
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 218.4 mg/kg/2 year- continuous
|
Liver: Other changes | Gastrointestinal: Other changes Blood: Changes in spleen
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 6,115.2 mg/kg/2 year- continuous
|
Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis)
|
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 1,820 mg/kg/2 year- continuous
|
Vascular: Thromobosis distant from injection site
|
TOLED5 132,221,2002
|
oral | rat
lowest published toxic dose: 15.3 gm/kg/510 day- continuous
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
TOLED5 132,153,2002
|
oral | rat
lowest published toxic dose: 1,995 mg/kg/570 day- continuous
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
TOLED5 132,153,2002
|
oral | rat
lowest published toxic dose: 609 mg/kg/174 day- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
TOLED5 132,153,2002
|
oral | rat
lowest published toxic dose: 910 mg/kg/91 day- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
TOLED5 132,153,2002
|
oral | rat
lowest published toxic dose: 30 mg/kg/3 day- continuous
|
Behavioral: Food intake (animal)
|
TOLED5 132,153,2002
|
oral | rat
lowest published toxic dose: 525 mg/kg/150 day- continuous
|
Behavioral: Food intake (animal)
|
TOLED5 132,153,2002
|
oral | rat
lowest published toxic dose: 21 mg/kg/6 day- continuous
|
Behavioral: Fluid intake
|
TOLED5 132,153,2002
|
oral | rat
lowest published toxic dose: 10.5 mg/kg/3 day- continuous
|
Behavioral: Fluid intake
|
TOLED5 132,153,2002
|
oral | rat
lowest published toxic dose: 2,548 mg/kg/2 year- continuous
|
Vascular: Structural changes in vessels | Liver: Other changes Reproductive: Paternal effects: Testes, epididymis, sperm duct
TOLED5 132,153,2002
|
oral | rat
lowest published toxic dose: 7,280 mg/kg/2 year- continuous
|
Gastrointestinal: Other changes
|
TOLED5 132,153,2002
|
oral | rat
lowest published toxic dose: 21.84 gm/kg/2 year- continuous
|
Kidney, Ureter, and Bladder: Other changes | Blood: Normocytic anemia Blood: Changes in spleen
TOLED5 132,153,2002
|
oral | rat
lowest published toxic dose: 2,548 mg/kg/2 year- continuous
|
Brain and Coverings: Other degenerative changes | Gastrointestinal: Other changes
TOLED5 132,153,2002
|
oral | rat
lowest published toxic dose: 7,280 mg/kg/2 year- continuous
|
Kidney, Ureter, and Bladder: Other changes
|
TOLED5 132,153,2002
|
oral | rat
lowest published toxic dose: 21.84 gm/kg/2 year- continuous
|
Liver: Other changes | Blood: Changes in spleen Reproductive: Maternal effects: Breasts, lactation (prior to or during pregnancy)
TOLED5 132,153,2002
|
oral | rat
lowest published toxic dose: 518 mg/kg/2 week- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
TOLED5 132,249,2002
|
oral | rat
lowest published toxic dose: 259 mg/kg/1 week- continuous
|
Behavioral: Food intake (animal)
|
TOLED5 132,249,2002
|
oral | rat
lowest published toxic dose: 140 mg/kg/1 week- continuous
|
Behavioral: Food intake (animal) | Behavioral: Fluid intake
TOLED5 132,249,2002
|
oral | rat
lowest published toxic dose: 77 mg/kg/1 week- continuous
|
Behavioral: Fluid intake
|
TOLED5 132,249,2002
|
skin | rat
lowest published toxic dose: 3,751 mg/kg/19 week- intermittent
|
Kidney, Ureter, and Bladder: Other changes in urine composition | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation)
GISAAA 41(10),103,1976
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 2 ppm (skin)
|
DTLVS* TLV/BEI,2003
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Confirmed Animal Carcinogen with Unknown
|
DTLVS* TLV/BEI,2003
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Limited Evidence
|
IMSUDL 7,79,1987
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 19,73,1979
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 71,43,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMEMDT 71,43,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 2B
|
IMEMDT 71,43,1999
|
TOXICOLOGY REVIEW
|
|
MUREAV 566,21,2004
|
TOXICOLOGY REVIEW
|
|
TOLED5 140-141,43,2003
|
TOXICOLOGY REVIEW
|
|
MUREAV 5432012003
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,227,2004
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,109,2004
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Mine Safety and Health Administration (MSHA) STANDARD - air
|
time-weighted average 20 ppm (45 mg/m3) (skin)
|
DTLVS* 3,6,1971
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)
|
8 hour time-weighted average 20 ppm (45 mg/m3) (skin)
|
CFRGBR 39,1926.55,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)
|
8 hour time-weighted average 20 ppm (45 mg/m3) (skin)
|
CFRGBR 41,50-204.50,1994
|
Occupational Safety and Health Administration (OSHA)
|
cancer hazard
|
CFRGBR 29,1910.1045,1987
|
Occupational Exposure Limit - ARAB Republic of Egypt
|
time-weighted average 2 ppm, Skin, JAN1993
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 2 ppm (4.5 mg/m3), Skin, Carcinogen, JAN1993
|
Occupational Exposure Limit - AUSTRIA
|
Skin, Carcinogen, JAN1999
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 2 ppm (4.3 mg/m3), Skin, Carcinogen JAN1993
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 2 ppm (4 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 2 ppm (4.5 mg/m3), short term exposure limit 4 ppm, Skin, Carcinogen, JAN1993
|
Occupational Exposure Limit - FRANCE
|
VME 2 ppm (4.5 mg/m3), VLE 15 ppm (32.4 mg/m3), continuous2 Carcinogen, JAN1999
|
Occupational Exposure Limit - GERMANY
|
Skin, Carcinogen, JAN1999
|
Occupational Exposure Limit - HUNGARY
|
short term exposure limit 0.5 mg/m3, Skin, Carcinogen, JAN1993
|
Occupational Exposure Limit - INDIA
|
time-weighted average 2 ppm (4.5 mg/m3), Skin, Carcinogen, JAN1993
|
Occupational Exposure Limit - JAPAN
|
Occupational Exposure Limit 2 ppm (4.3 mg/m3), Skin, 2A Carcinogen, JAN1999
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 2 ppm (4 mg/m3), JAN1999
|
Occupational Exposure Limit - THE PHILIPPINES
|
time-weighted average 20 ppm (45 mg/m3), Skin, JAN1993
|
Occupational Exposure Limit - POLAND
|
MAC(time-weighted average) 2 mg/m3, MAC(short term exposure limit) 10 mg/m3, JAN1999
|
Occupational Exposure Limit - RUSSIA
|
time-weighted average 2 ppm, short term exposure limit 0.5 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - SWEDEN
|
NGV 2 ppm (4.5 mg/m3), KTV 6 ppm, Skin, Carcinogen, JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 2 ppm (4.5 mg/m3), Skin, Carcinogen, JAN1999
|
Occupational Exposure Limit - TURKEY
|
time-weighted average 20 ppm (45 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 2 ppm (4.4 mg/m3), Skin, Carcinogen, SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Confirmed Animal Carcinogen with Unknown
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Confirmed Animal Carcinogen with Unknown |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO ACRYLONITRILE-air
|
Carcinogen; | 8 hour time-weighted average 1 ppm; ceiling concentration 10 ppm/15 minute (Sk)
NIOSH* DHHS #92-100,1992
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 03800; | Number of Industries 45; Total Number of Facilities 3,610; Number of Occupations 55; Total Number of Employees Exposed 55,698
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 03800; |
Number of Industries 24; Total Number of Facilities 2,522; Number of Occupations 39; Total Number of Employees Exposed 81,691; Total Number of Female Employees Exposed 27,358 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; SHE-focus assay
|
EPA GENETOX PROGRAM 1988, Positive: Cell transform.-SA7/SHE; Histidine reversion-Ames test
|
EPA GENETOX PROGRAM 1988, Positive: TRP reversion
|
EPA GENETOX PROGRAM 1988, Positive/dose response: TRP reversion
|
EPA GENETOX PROGRAM 1988, Inconclusive: D melanogaster Sex-linked lethal
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used in the manufacture of acrylic and modacrylic fibers
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH CURRENT INTELLIGENCE BULLETIN 18, 1977
|
NIOSH Analytical Method, 1994: Acrylonitrile, 1604
|
NCI Carcinogenesis Studies (gavage);clear evidence:mouse
|
NTP 10th Report on Carcinogens,2002:Reasonably anticipated to be a human carcinogen
|
NTP Carcinogenesis studies; on test (two year studies), October 2000
|
OSHA ANALYTICAL METHOD #37
|
|
REFERENCES:
CODEN
|
|
REFERENCE
AMPMAR
|
Archives des Maladies Professionnelles de Medecine du Travail et de Securite Sociale. (SPPIF,
B.P.22, F-41353 Vineuil, France) V.7- 1946-
|
ANYAA9
|
Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New
York, NY 10021) V.1- 1877-
|
ATDAEI
|
Acute Toxicity Data. Journal of the American College of Toxicology, Part B. (Mary Ann Liebert,
Inc., 1651 Third Ave., New York, NY 10128) V.1- 1990-
|
CALEDQ
|
Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1975-
|
CBINA8
|
Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1969-
|
CFRGBR
|
Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402)
|
CNREA8
|
Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA
19106) V.1- 1941-
|
CRNGDP
|
Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford
OX8 1JJ, UK) V.1- 1980-
|
CRTXB2
|
CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton,
FL 33431) V.1- 1971-
|
DMWOAX
|
Deutsche Medizinische Wochenschrift. (Stuttgart, Fed. Rep. Ger.) V.1-104, 1875-1979.
|
DOWCC*
|
Dow Chemical Company Reports. (Dow Chemical USA, Health and Environment Research, Toxicology
Research Lab., Midland, MI 48640)
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
EESADV
|
Ecotoxicology and Environmental Safety. (Academic Press, Inc., 1 E. First St., Duluth, MN
55802) V.1- 1977-
|
EKFAE9
|
Eksperimental'naya i Klinicheskaya Farmakologiya. Experimental and Clinical Pharmacology.
(Mezhdunarodnaya Kniga, ul. B. Yakimanka, 39, 117049 Moscow, Russia) V.55- 1992-
|
FAATDF
|
Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1-40, 1981-97. For publisher information, see TOSCF2
|
FCTOD7
|
Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.20- 1982-
|
FCTXAV
|
Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see
FCTOD7.
|
GISAAA
|
Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga,
113095 Moscow, USSR) V.1- 1936-
|
GTPZAB
|
Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O
Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see
MTPEEI
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
IMSUDL
|
IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY
12210) No.1- 1979-
|
INMEAF
|
Industrial Medicine. (Chicago, IL) V.1-18, 1932-49. For publisher information, see IOHSA5.
|
JHEMA2
|
Journal of Hygiene, Epidemiology, Microbiology, and Immunology. (Avicenum, Malostranske
namesti 28, 11802 Prague 1, Czechoslovakia) V.1- 1957-
|
JIHTAB
|
Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For
publisher information, see AEHLAU.
|
JJATDK
|
JAT, Journal of Applied Toxicology. (John Wiley & Sons Ltd., Baffins Lane, Chichester, W.
Sussex PO19 1UD, UK) V.1- 1981-
|
JJIND8
|
JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For
publisher information, see JNCIEQ.
|
MELAAD
|
Medicina del Lavoro. Industrial Medicine. (Via S. Barnaba, 8, 20122 Milan, Italy) V.16-
1925-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
PMRSDJ
|
Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New
York, NY 10017) V.1- 1981-
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
WDZAEK
|
Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu,
Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987
|
XENOBH
|
Xenobiotica. (Taylor & Francis Ltd., 4 John St., London WC1N 2ET, UK) V.1- 1971-
|
ZAARAM
|
Zentralblatt fuer Arbeitsmedizin und Arbeitsschutz. (Darmstadt, Fed. Rep. Ger.) V.1-25,
1951-75.
|
ZHYGAM
|
Zeitschrift fuer die Gesamte Hygiene und Ihre Grenzgebiete. (VEB Verlag Volk und Gesundheit,
Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1955-
|
|